Drug Patents owned by Telix

1. Drug name - ILLUCCIX

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US11027031 TELIX Kit for radiolabelling Jul, 2035

(12 years from now)

Drugs and Companies using GALLIUM GA-68 GOZETOTIDE ingredient

Treatment: Positron emission tomography (pet) of prostate-specific membrane antigen (psma) positive lesions in men with prostate cancer

Dosage: POWDER;INTRAVENOUS

More Information on Dosage
Strength Dosage Availability
6.7mCi/ML POWDER;INTRAVENOUS Prescription

availability in other generic markets.

Click on the highlighted region to filter.